Abstract
To identify critical tumor suppressor loci that are associated with the development of medulloblastoma, we performed a comprehensive genome-wide allelotype analysis in a series of 12 medulloblastomas. Non-random allelic imbalances were identified on chromosomes 7q (58.3%), 8p (66.7%), 16q (58.3%), 17p (58.3%) and 17q (66.7%). Comparative genomic hybridization analysis confirmed that allelic imbalances on 8p, 16q and 17p were due to loss of genetic materials. Finer deletion mapping in an expanded series of 23 medulloblastomas localized the common deletion region on 8p to an interval of 18.14 cM on 8p22–23.2. We then searched within the region of loss on 8p for loci that might contain homozygous deletion using comparative duplex PCR. An overlapping homozygous deletion region was identified in a 1.8 cM interval on 8p22–23.1, between markers D8S520 and D8S1130, in two medulloblastomas. This region of homozygous deletion also encompasses the 1.4 cM minimal deletion region detected on 8p in ductal carcinoma in situ of breast. In conclusion, we reported for the first time a detailed deletion mapping on 8p in medulloblastoma and have identified a region of homozygous deletion on 8p22–23.1 that is likely to contain a critical tumor suppressor gene involved in the development of medulloblastoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arbieva ZH, Banerjee K, Kim SY, Edassery SL, Maniatis VS, Horrigan SK, Westbrook CA . 2000 Genome Res. 10: 244–527
Avet-Loiseau H, Venuat AM, Terrier-Lacombe MJ, Lellouch-Tubiana A, Zerah M, Vassal G . 1999 Br. J. Cancer 79: 1843–1847
Baffa R, Santoro R, Bullrich F, Mandes B, Ishii H, Croce CM . 2000 Clin. Cancer Res. 6: 1372–1377
Bigner SH, Mark J, Friedman HS, Biegel JA, Bigner DD . 1988 Cancer Genet. Cytogenet. 30: 91–101
Blaeker H, Rasheed BK, McLendon RE, Friedman HS, Batra SK, Fuchs HE, Bigner SH . 1996 Genes Chromosomes Cancer 15: 54–63
Bova GS, MacGrogan D, Levy A, Pin SS, Bookstein R, Isaacs WB . 1996 Genomics 35: 46–54
Broman KW, Murray JC, Sheffield VC, White RL, Weber JL . 1998 Am. J. Human Genet. 63: 861–689
Farrington SM, Cunningham C, Boyle SM, Wyllie AH, Dunlop MG . 1996 Oncogene 12: 1803–1808
Fujiwara Y, Emi M, Ohata H, Kato Y, Nakajima T, Mori T, Nakamura Y . 1993 Cancer Res. 53: 1172–1174
Gilhuis HJ, Anderl KL, Boerman RH, Jeuken JM, James CD, Raffel C, Scheithauer BW, Jenkins RB . 2000 Clin. Neurol. Neurosurg. 102: 203–209
Giangaspero F, Bigner SH, Kleihues P, Pietsch T, Trojanowski JQ . 2000 Pathology and Genetics of Tumors of the Nervous System Kleihues P and Cavenee WK. (eds) IARC Press: Lyon pp 129–137
Heideman RL, Packer RJ, Albright LA, Freeman CR, Rorke LB . 1997 Principles and Practice of Pediatric Oncology Pizzo PA and Poplack DG. (ed) Lippincott-Raven: New York pp 651–656
Ishii H, Baffa R, Numata SI, Murakumo Y, Rattan S, Inoue H, Mori M, Fidanza V, Alder H, Croce CM . 1999 Proc. Natl. Acad. Sci. USA 96: 3928–3933
Ishii H, Vecchione A, Murakumo Y, Baldassarre G, Numata S, Trapasso F, Alder H, Baffa R, Croce CM . 2001 Proc. Natl. Acad. Sci. USA 98: 10374–10379
Ishwad CS, Shuster M, Bockmuhl U, Thakker N, Shah P, Toomes C, Dixon M, Ferrell RE, Gollin SM . 1999 Int. J. Cancer 80: 25–31
Kagan J, Stein J, Babaian RJ, Joe YS, Pisters LL, Glassman AB, von Eschenbach AC, Troncoso P . 1995 Oncogene 11: 2121–2126
Jenkins R, Takahashi S, DeLacey K, Bergstralh E, Lieber M . 1998 Genes Chromosomes Cancer 21: 131–143
Lassus H, Laitinen MP, Anttonen M, Heikinheimo M, Aaltonen LA, Ritvos O, Butzow R . 2001 Lab. Invest. 81: 517–526
Levy A, Dang UC, Bookstein R . 1999 Genes Chromosomes Cancer 24: 42–47
Leung YF, Tam PO, Tong WC, Baum L, Choy KW, Lam DS, Pang CP . 2001 Biotechniques 30: 334–335 338–340
Ng IO, Liang ZD, Cao L, Lee TK . 2000 Cancer Res. 60: 6581–6584
Nicholson JC, Ross FM, Kohler JA, Ellison DW . 1999 Br. J. Cancer 80: 1322–1331
Nihei N, Ichikawa T, Kawana Y, Kuramochi H, Kugoh H, Oshimura M, Hayata I, Shimazaki J, Ito H . 1996 Genes Chromosomes Cancer 17: 260–268
Pineau P, Nagai H, Prigent S, Wei Y, Gyapay G, Weissenbach J, Tiollais P, Buendia MA, Dejean A . 1999 Oncogene 18: 3127–3134
Prasad MA, Trybus TM, Wojno KJ, Macoska JA . 1998 Genes Chromosomes Cancer 23: 255–262
Reardon DA, Michalkiewicz E, Boyett JM, Sublett JE, Entrekin RE, Ragsdale ST, Valentine MB, Behm FG, Li H, Heideman RL, Kun LE, Shapiro DN, Look AT . 1997 Cancer Res. 57: 4042–4047
Saylors III RL, Sidransky D, Friedman HS, Bigner SH, Bigner DD, Vogelstein B, Brodeur GM . 1991 Cancer Res. 51: 4721–4723
Schmitz AAP, Govek EE, Bottner B, Van Aelst L . 2000 Exp. Cell. Res. 261: 1–12
Sun PC, Schmidt AP, Pashia ME, Sunwoo JB, Scholnick SB . 1999 Genomics 62: 184–188
Sunwoo JB, Sun PC, Gupta VK, Schmidt AP, El-Mofty S, Scholnick SB . 1999 Oncogene 18: 2651–2655
Takle LA, Knowles MA . 1996 Oncogene 12: 1083–1087
Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Konishi M, Oshimura M, Miyaki M . 1996 Oncogene 12: 405–410
Tong CY, Zheng PP, Pang JC, Poon WS, Chang AR, Ng HK . 2001 J. Neurosurg. 95: 9–14
Vecchione A, Ishii H, Shiao YH, Trapasso F, Rugge M, Tamburrino JF, Murakumo Y, Alder H, Croce CM, Baffa R . 2001 Clin. Cancer Res. 7: 1546–1552
von Deimling A, Fimmers R, Schmidt MC, Bender B, Fassbender F, Nagel J, Jahnke R, Kaskel P, Duerr EM, Koopmann J, Maintz D, Steinbeck S, Wick W, Platten M, Muller DJ, Przkora R, Waha A, Blumcke B, Wellenreuther R, Meyer-Puttlitz B, Schmidt O, Mollenhauer J, Poustka A, Stangl AP, Lenartz D, von Ammon K . 2000 J. Neuropathol. Exp. Neurol. 59: 544–558
Wang JC, Radford DM, Holt MS, Helms C, Goate A, Brandt W, Parik M, Phillips NJ, DeSchryver K, Schuh ME, Fair KL, Ritter JH, Marshall P, Donis-Keller H . 1999 Genomics 60: 1–11
Wilson PJ, McGlinn E, Marsh A, Evans T, Arnold J, Wright K, Biden K, Young J, Wainwright B, Wicking C, Chenevix-Trench G . 2000 Hum. Mutat. 15: 156–165
Wistuba II, Behrens C, Virmani AK, Milchgrub S, Syed S, Lam S, Mackay B, Minna JD, Gazdar AF . 1999 Cancer Res. 59: 1973–1979
Wright K, Wilson PJ, Kerr J, Do K, Hurst T, Khoo SK, Ward B, Chenevix-Trench G . 1998 Oncogene 17: 1185–1188
Yaremko ML, Kutza C, Lyzak J, Mick R, Recant WM, Westbrook CA . 1996 Genes Chromosomes Cancer 16: 189–195
Yin XL, Pang JC, Liu YH, Chong EY, Cheng Y, Poon WS, Ng HK . 2001 J. Neurosurg. 94: 799–805
Yin XL, Pang JC, Hui AB, Ng HK . 2000 J. Neurosurg. 93: 77–81
Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS, Popescu NC . 1998 Cancer Res. 58: 2196–2199
Acknowledgements
This study was supported by a Direct Grant from the Research Grant Council of Hong Kong.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yin, Xl., Pang, Js. & Ng, Hk. Identification of a region of homozygous deletion on 8p22–23.1 in medulloblastoma. Oncogene 21, 1461–1468 (2002). https://doi.org/10.1038/sj.onc.1205204
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205204